# Resveratrol for Alzheimer's Disease

> **NCT01504854** · PHASE2 · COMPLETED · sponsor: **Alzheimer's Disease Cooperative Study (ADCS)** · enrollment: 119 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Resveratrol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01504854
- **Lead sponsor:** Alzheimer's Disease Cooperative Study (ADCS)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2016-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504854, "Resveratrol for Alzheimer's Disease". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01504854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*